Health Fact Sheets
Chronic obstructive pulmonary disease under-diagnosed in Canadian adults: Results from cycles 3 and 4 (2012 to 2015) of the Canadian Health Measures Survey
Results from cycles 3 and 4 (2012 to 2015) of the Canadian Health Measures Survey (CHMS) suggest that chronic obstructive pulmonary disease (COPD) is under-diagnosed in Canadian adults. This is based on the disparity between the proportion of Canadian adults who reported having been diagnosed with COPD and the proportion of Canadian adults who had a measured airflow obstruction consistent with COPD.
COPD is a condition characterized by a progressive and chronic airflow obstruction, shortness of breath, persistent wheezing and coughing, and sputum production that occurs primarily in adults over the age of 35. Chronic bronchitis and emphysema are the two most common forms of COPD and cigarette smoking is responsible for 80% to 90% of all COPD cases,Note 1 suggesting that the majority of cases can be prevented. Other contributing factors may include outdoor, indoor and occupational air pollution.Note 1 Although airflow obstruction is not fully reversible, COPD can be treated and the symptoms controlled with proper medication and exercise programs.Note 2Note 3
The CHMS used a health questionnaire to determine whether or not respondents were previously diagnosed with COPD.Note 4 Respondents considered to have diagnosed COPD were those who reported having been diagnosed with COPD, chronic bronchitis or emphysema by a health care professional. Combined data from cycles 3 and 4 (2012 to 2015) of the CHMS showed that 3% of Canadians aged 35 to 79 years reported a diagnosis of COPD (Chart 1). The prevalence of self-reported COPD diagnosis was not significantly different for men (3%) and women (4%). COPD diagnosis reporting was significantly greater in older adults aged 60 to 79 years (6%) than younger adults aged 35 to 59 years (2%).
The CHMS also conducted a spirometry test to measure lung function (see “About spirometry and COPD” below). The results from cycles 3 and 4 (2012 to 2015) indicate that 12% of Canadians 35 to 79 years of age had a measured airflow obstruction consistent with COPD (Chart 1). The prevalence of measured COPD did not differ significantly between sexes nor between age groups.
There were, however, significant differences between the prevalence of self-reported and measured COPD (Chart 1).
Data table for Chart 1
|Self-reported COPD||Measured COPD|
|Males||3Note E: Use with caution||10Note *|
|Aged 35 to 59||2Note E: Use with caution||12Note *|
|Aged 60 to 79||6Note **||10|
E use with caution
Among the 12% of 35- to 79-year old Canadians with measured airflow obstruction consistent with COPD, only 11% reported that they had previously been diagnosed by a health care professional (Chart 2). When asked, the vast majority (89%) reported that they had not previously been diagnosed by a health care professional.
Under-diagnosis was the least prevalent among older adults. Over 24% of the 60- to 79-year old population with measured airflow obstruction consistent with COPD reported a diagnosis whereas only 6% of the 35- to 59-year-olds were aware of their condition (data not shown).
On the other hand, 2% of the 35- to 79-year old population with normal lung function results reported that they had been diagnosed with COPD by a health care professional (data not shown). However, it could not be determined whether this was due to an over-diagnosis of COPD or to the use of medication to control airflow obstruction.
Description for Chart 2
The pie chart has the following 2 sections:
- No measured COPD, 88%
- Measured COPD, 12%
The “Measured COPD” section of the pie chart also has the following 2 sub-sections:
- Measured and self-reported COPD, 11%
- Measured but not self-reported COPD, 89%
- Note 1
Self-reported COPD is based on a self-reported diagnosis of COPD, chronic bronchitis or emphysema by a health care professional.
Measured COPD is defined as having a forced expiratory volume for one second to the forced vital capacity (FEV1/FVC) ratio less than the lower limit of normal (LLN).
Results from the cycles 3 and 4 (2012 to 2015) of the CHMS support the link between COPD and smoking noted in the literature.Note 1 Of the 12% of 35- to 79-year-olds with measured COPD, 74% of them reported that they were smokers or had a history of smoking (data not shown).
Start of text box
Spirometry is a functional tool that measures the volume of air an individual inhales and exhales in addition to the speed at which the air is moved in or out of the lungs. In the same manner that blood pressure measurements provide important information about general cardiovascular health, spirometry is invaluable as a screening tool for general respiratory health. Used alongside other respiratory tests, spirometry allows medical practitioners to monitor respiratory health for conditions such as COPD. Spirometry results are interpreted by comparing measurements to the expected values for a normal healthy individual of the same sex and similar age with the same body dimensions and ethnic characteristics.Note 5
The spirometry measurements of primary interest for COPD diagnosis are:
- Forced vital capacity (FVC): the total volume of air that can be forcibly exhaled after a maximum inspiration.
- Forced expiratory volume in one second (FEV1): the volume of air that can be forcibly exhaled in the first second of a FVC manoeuvre.
- The FEV1 to FVC ratio (FEV1/FVC) is used as the value for diagnostic purposes.
Self-reported COPD was determined from the health questionnaire administered as part of the CHMS. Respondents were asked if they had ever been diagnosed with COPD, chronic bronchitis or emphysema by a health care professional.
An airflow obstruction consistent with COPD was based on measured spirometry results where the FEV1/FVC was below the lower limit of normal (LLN).Note 6 The LLN takes into account ethnicity, height, age and sex, and establishes a cut-off value for the FEV1/FVC. This value represents the highest FEV1/FVC ratio among the 5% of the population with the lowest FEV1/FVC results. In other words, 95% of the healthy population falls above this set value. This approach allows for a more appropriate and accurate measure and diagnosis of COPD.Note 7Note 8 However, it is important to note that asthma also causes a reduction in spirometry measurements and could not be separated for this report as a post-bronchodilator test was not administered.
End of text box
Canadian Health Measures Survey data related to this fact sheet are available in CANSIM table 117-0011.
For more information on the Canadian Health Measures Survey, please contact Statistics Canada's Statistical Information Service (toll-free 1-800-263-1136; 514-283-8300; STATCAN.infostats-infostats.STATCAN@canada.ca).
Aussi disponible en français.